Should I Buy SWOBY Stock in 2026?
Data-driven analysis and honest assessment for Swedish Orphan Biovitrum AB (publ)
Current Price: $19.63P/E: 280.4
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Very high P/E of 280.4 suggests overvaluation
Slow growth of 0%
Thin margins (0% net)
Financial health data limited
Excellent FCF yield of 56.0%
No recent insider activity
Key Investment Metrics
Current Price
$19.63
P/E Ratio
280.39
Revenue Growth
0.1%
Profit Margin
0.0%
Market Cap
$14.2B
Dividend Yield
None
How SWOBY Compares to Competitors
Understanding how SWOBY stacks up against peers helps inform your investment decision.
How SWOBY Compares to Peers
Upcoming Events for SWOBY
+5 Reasons TO Buy SWOBY
1. High gross margins of 78%
strongGross margins above 50% typically indicate strong brand value or intellectual property moats.
2. High free cash flow yield of 56.0%
strongFCF yield above 5% means substantial cash generation for dividends, buybacks, or reinvestment.
-5 Reasons NOT to Buy SWOBY
1. Expensive valuation at 280x earnings
high riskP/E of 280 is significantly above averages. High expectations leave little room for disappointment.
2. Thin profit margins of 0.0%
high riskLow margins provide little cushion against cost increases or pricing pressure.
3. Minimal revenue growth
low riskGrowth of 0.1% barely keeps pace with inflation.
Who Should Buy SWOBY?
Investment Profile
Risk Level
High
Recommended Holding Period
3-5 years
Best For:
- ✓
Momentum Traders
High-growth profile attracts momentum
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Value Investors
Premium P/E of 280 doesn't fit value criteria
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
Consider These Alternatives
If you're interested in SWOBY, compare these Healthcare peers:
Pro tip: Compare SWOBY directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for SWOBY
Frequently Asked Questions
What is SWOBY stock price today?
SWOBY (Swedish Orphan Biovitrum AB (publ)) stock is trading at $19.63 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is SWOBY stock going up or down today?
SWOBY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy SWOBY stock now?
The decision to buy SWOBY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is SWOBY a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for SWOBY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is SWOBY stock overvalued or undervalued?
SWOBY currently trades at a P/E ratio of 280.39, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if SWOBY is fairly priced.
What is SWOBY's P/E ratio?
SWOBY has a price-to-earnings (P/E) ratio of 280.39, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is SWOBY's market cap?
SWOBY (Swedish Orphan Biovitrum AB (publ)) has a market capitalization of $14.20 billion, making it a mid-cap stock.
What is SWOBY's price to book ratio?
SWOBY trades at a price-to-book (P/B) ratio of 3.41, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Swedish Orphan Biovitrum AB (publ)
Full Stock Analysis
Complete SWOBY overview with charts and data
Is SWOBY Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how SWOBY stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Swedish Orphan Biovitrum AB (publ)
Complete SWOBY Analysis
Compare SWOBY With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.